Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization

References

• Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol 2001;12:242–249
   PubMed Web of Science ®Google Scholar
• Ormerod LD, Abelson MB, Kenyon KR. Standard models of corneal injury using alkali-immersed filter discs. Invest Ophthalmol Vis Sci 1989;30:2148–2153
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–257
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487
   PubMed Web of Science ®Google Scholar
• Ma X, Ottino P, Bazan HE, Bazan NG. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Invest Ophthalmol Vis Sci 2004;45:2915–2921
   PubMed Web of Science ®Google Scholar
• Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97–145
   PubMed Web of Science ®Google Scholar
• Fukuda AI, Breuel KF. Effect of platelet activating factor on embryonic development and implantation in the mouse. Hum Reprod 1996;11:2746–2749
   PubMed Web of Science ®Google Scholar
• Nilsson G, Metclfe DD, Taub DD. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 2000;99:314–319
   PubMed Web of Science ®Google Scholar
• Toledano BJ, Bastien Y, Noya F, Mazer B. Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. Cell Immunol 1999;191:60–68
   PubMed Web of Science ®Google Scholar
• Bazan HEP, Tao Y, Hurst JS. Platelet-activating factor antagonists and ocular inflammation. J Ocul Pharmacol 1994;10:319–327
   PubMedGoogle Scholar
• Okumura N, Fukushima A, Igarashi A, et al. Pharmacokinetc analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis. J Ocul Pharmacol Ther 2006;22:347–352
   PubMed Web of Science ®Google Scholar
• Bazan HEP, Reddy STK, Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res 1991;52:481–491
   PubMed Web of Science ®Google Scholar
• Lin N, Bazan HEP, Braquet P, Bazan NG. Prolonged effect of a new platelet-activating factor antagonists on ocular vascular permeability in an endotoxin model of uveitis. Curr Eye Res 1991;10:19–24
   PubMed Web of Science ®Google Scholar
• Ma X, Bazan HE. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2000;41:1696–1702
   PubMed Web of Science ®Google Scholar
• Yoshida S, Yoshida A, Ishibashi T, et al. Role of MCP-1 and MIP-1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukocyte Biol 2003;73:137–144
   PubMed Web of Science ®Google Scholar
• Sotozono C, He J, Matsumoto Y, et al. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997;16:670–676
   PubMed Web of Science ®Google Scholar
• Li ZR, Li YP, Lin ML, et al. Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneas. Cornea 2012;31:102810–102835
   Google Scholar
• Xiao O, Xie ZL, Lin BW, et al. Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS One 2012;7:e41858
   PubMed Web of Science ®Google Scholar
• Yang L, Wang Y, Zhou Q, et al. Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization. Mol Vis 2009;15:1951–1961
   PubMed Web of Science ®Google Scholar
• Lai CM, Spilsbury K, Brankov M, et al. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 2002;75:625–634
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040–1050
   PubMed Web of Science ®Google Scholar
• Ortego J, Escribano J, Becerra SP, Coca-Prados M. Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest Ophthalmol Vis Sci 1996;37:2759–2767
   PubMed Web of Science ®Google Scholar
• He J, Bazan NG, Bazan HEP. Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol 2006;124:70–78
   PubMed Web of Science ®Google Scholar
• Zhu SN, Dana MR. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci 1999;40:1427–1434
   PubMed Web of Science ®Google Scholar
• Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 2006;82:46–54
   PubMed Web of Science ®Google Scholar
• Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000;19:113–129
   PubMed Web of Science ®Google Scholar
• Taub DD, Proost P, Murphy WJ, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370–1376
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Matsushima K, Tanaka S, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84:9233–9237
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Elner VM, et al. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992;141:1279–1284
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Ghazanfari T, Yaraee R, et al. Roles of IL-8 in ocular inflammations: a review. Ocul Immunol Inflamm 2011;19:401–412
   PubMed Web of Science ®Google Scholar
• Camussi G, Montrucchio G, Lupia E, et al. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995;154:6492–6501
   PubMed Web of Science ®Google Scholar
• Montrucchio G, Lupia E, Battaglia E, et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 2000;20:80–88
   PubMed Web of Science ®Google Scholar
• Ko HM, Seo KH, Han SJ, et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002;62:1809–1814
   PubMed Web of Science ®Google Scholar